Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jean-Pierre Riffaud"'
Autor:
Sandra Huguenin, Jean-Pierre Riffaud, Marie-Claude Jaurand, Jocelyne Fleury-Feith, Manlio Bolla, Dominique K. Chopin, Francis Vacherot
Publikováno v:
Cancer Letters. 218:163-170
Our work aimed at identifying the antitumoral potential of new nitric oxide (NO)-releasing non-steroidal anti-inflammatory drug (NSAID) derivatives on human prostate and bladder carcinoma cell lines. Among all molecules tested, two sulindac derivativ
Autor:
Sandra, Huguenin, Francis, Vacherot, Laurence, Kheuang, Jocelyne, Fleury-Feith, Marie-Claude, Jaurand, Manlio, Bolla, Jean-Pierre, Riffaud, Dominique K, Chopin
Publikováno v:
Molecular Cancer Therapeutics. 3:291-298
Non-steroidal anti-inflammatory drugs (NSAIDs) are potent antitumoral agents but their side effects limit their clinical use. A novel class of drugs, nitric oxide-donating NSAIDs (NO-NSAIDs), was found to be safer and more active than classical NSAID
Autor:
Yuri Novitsky, Robert M. Levin, Jean-Pierre Riffaud, Robert E. Leggett, Anurag K. Das, Niels Haugaard, Patrick Horan, Penelope A. Longhurst
Publikováno v:
Neurourology and Urodynamics. 16:583-599
Tadenan (Debat Laboratories, France) is a plant extract used in Europe for the treatment of micturition disorders associated with benign prostatic hypertrophy (BPH). Prior studies demonstrated that pretreatment of rabbits with Tadenan significantly r
Autor:
Jean-Pierre Riffaud
Publikováno v:
Essential Readings in Light Metals ISBN: 9783319485744
Essential Readings in Light Metals: Alumina and Bauxite, Volume 1
Essential Readings in Light Metals: Alumina and Bauxite, Volume 1
This paper will review the evolution of process control in the alumina industry. The comparison with others such as Oil and Gas will be useful to measure where we are now and what other steps, particularly in advanced control, we can envisage to brin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76bfef5f2d04139c2a10576404855622
https://doi.org/10.1002/9781118647868.ch117
https://doi.org/10.1002/9781118647868.ch117
Publikováno v:
Current Therapeutic Research. 56:796-817
Pygeum africanum bark extract has been used to treat mild and moderate symptomatic benign prostatic hyperplasia (BPH) in France since 1969. The extract has several potentially relevant pharmacologic properties: modulation of age-related hypercontract
Autor:
Jean-Yves Lacolle, Antonio De Almeida, Monique Bachir, Bernard Danree, Jean Lemoine, Jean-Pierre Riffaud, Patrick Houziaux
Publikováno v:
European Journal of Medicinal Chemistry. 25:71-74
During the search for new biologically active agents in the thiazole field, some 2-( N -substituted glycylamino)-4-methyl thiazoles were synthesized. Preliminary pharmacological evaluation showed that these compounds exhibited anticonvulsant activity
Autor:
L. Kheuang, Dominique K. Chopin, Jocelyne Fleury-Feith, Sandra Huguenin, Jean-Pierre Riffaud, Manlio Bolla, Francis Vacherot, Marie-Claude Jaurand
Publikováno v:
The Prostate. 61(2)
BACKGROUND The aim of our study was to explore the anti-tumoral potential of the Nitric Oxide-Donating Non-Steroidal Anti-Inflammatory Drugs (NO-NSAID) NCX1102 (nitrosulindac), on three human prostatic epithelial cell lines at varying degree of trans
Publikováno v:
The Journal of urology. 157(6)
The effect of a Pygeum africanum extract (Tadenan) (Pa), used in the treatment of micturition disorders associated with BPH, has been examined on the proliferation of rat prostatic stromal cells stimulated by different growth factors. EGF, bFGF, and
Publikováno v:
European Journal of Pharmacology. 183:463-464
Autor:
Sandra Huguenin, Jocelyne Fleury?Feith, Laurence Kheuang, Marie?Claude Jaurand, Manlio Bolla, Jean?Pierre Riffaud, Dominique K. Chopin, Francis Vacherot
Publikováno v:
Prostate; Oct2004, Vol. 61 Issue 2, p132-141, 10p